Efficacy of Granulocyte-Colony Stimulating Factor (G-CSF)

• Status: Unknown status
• Trial end date: 2019-08-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study was to analyze the clinical factors associated with the effect of Granulocyte-Colony Stimulating Factor (G-CSF).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: DERSHENG SUN
• Treatments: Lenograstim

Criteria

Inclusion Criteria:

1. Patients diagnosed with solid cancer and blood cancer

2. Patients who received chemotherapy with moderate risk (Appendix 1, Appendix 2)

3. CTCAE version 4.0 showed grade 4 neutropenia, grade 3 neutropenia (blood cancer), Decreased grade 3 neutrophils with fever (solid cancer)

4. Those who understand and agree with the purpose of the research

Exclusion Criteria:

• 1) Patients with hypersensitivity to G-CSF 2) Patients not diagnosed with hematologic tumor 3) grade 1, grade 2 or more neutropenia 4) Patients who did not sign a consent agreement